On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now Blog

All posts by Christopher

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

  • The two companies signed a manufacturing operating agreement and a commercial agreement
  • Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023
  • The FDA has acknowledged Lexaria’s pre-IND request and responded with conditions prior to the target date of July 30, 2022

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only furthers Lexaria’s leverage of the market, with the company’s patented DehydraTECH(TM) technology having already been embraced by several consumer packaged goods brands, with availability in over 7,000 stores throughout the United States and Japan, including direct-to-consumer online retail portals (https://ibn.fm/gLQzN).

The manufacturing operating agreement expands the production capabilities of Lexaria’s growing list of business-to-business clientele interested in purchasing DehydraTECH-powered active ingredients for packaged-goods brands. The new, state-of-the-art processing facility built by BevNology is operational, increasing and broadening production capabilities. This facility is currently serving Lexaria’s corporate clientele, with new equipment specific to DehydraTECH already installed.

The second agreement is a commercial license, empowering BevNology to offer the DehydraTECH products with active ingredients derived from hemp, including cannabidiol (“CBD”), under BevNology and partnered brands. The agreement is non-exclusive for powdered DehydraTECH formulations. For liquid formulations, the non-exclusivity is limited in the United States only, requiring certain minimum fee payments to maintain rights. Lexaria will receive royalties from BevNology for the utilization under this license, with exclusion only affecting Japan, the Republic of Korea, and the People’s Republic of China.

“These agreements build on a long-standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology.” Lexaria CEO Chris Bunka said. “BevNology’s formulation and production capabilities are class leading, and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.”

In other recent news, Lexaria has filed its pre-IND meeting request letter with the United States Food and Drug Administration (“FDA”) to initiate communication with the FDA regarding Lexaria’s development of the company’s DehydraTECH-CBD for potential hypertension treatment. The FDA has responded to and confirmed the company’s letter, with a target date of July 30, 2022, and disclosed the conditions in which Lexaria must meet prior to the meeting. Lexaria anticipates filing the full IND application in late 2022/early 2023 (https://ibn.fm/MpKmr).

“We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” stated John Docherty, President of Lexaria. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.”

The hypertension treatment market is valued at approximately $28 billion per year and is expected to grow as one of the world’s top health problems as a subset of a larger heart disease market (https://ibn.fm/sIjQJ). There are over 1.1 billion people in the world suffering from hypertension, with fewer than 1 in 4 having successful control over it. The potential market size increases if an affordable drug were available with few or no side effects. Some reports indicate drugs for hypertension and related conditions are among the highest-selling category of drugs in the world (https://ibn.fm/oAxXN).

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

Odyssey Health, Inc. (ODYY) Taps Military Advisors to Address Target Market for PRV-002 Concussion Drug

  • Odyssey Health is a medical company focused on developing medical products for conditions with unmet needs, one of which is concussion
  • Currently, concussions do not have an FDA-approved treatment
  • Soldiers form a significant population of people who frequently experience multiple concussions throughout their career
  • Concussion has only recently received greater attention as different parties seek to understand the condition and possible treatments
  • Odyssey is at the forefront of this pursuit for treatment and has developed the PRV-002 drug candidate that it intends to use on the military as part of a Phase II clinical trial
  • The company announced the formation of a Military Advisory Board to help in this journey

According to a study by the Business Development Bank of Canada (“BDC”), 86% of businesses with an advisory board say it has had a substantial impact on their operations. In addition, the study showed that companies with an advisory board witnessed 24% higher annual sales and 18% higher productivity than businesses without one (https://ibn.fm/K437C).

Looking to tap into these favorable statistics as well as to better understand one of its important target markets, the military, Odyssey Health (OTC: ODYY), a medical company focused on unique, life-saving medical products that offer clinical advantages to conditions with unmet needs, announced the formation of a Military Advisory Board (https://ibn.fm/LJwwD).

The board, which comprises associated military contacts (retired members of the U.S. armed forces who previously held leadership positions), was formed to gain experience and information that will provide crucial insights into traumatic brain injuries (“TBI”) and their effects on those who sustain TBI.

“TBI in general, and mild TBI in particular, is considered a ‘silent epidemic’ because many of the acute and enduring alterations in cognitive, motor, and somatosensory functions may not be readily apparent to external observers,” an article published in the National Institutes of Health (“NIH”)’s National Library of Medicine website reads (https://ibn.fm/0P7nE). The article goes on to note that approximately 80% of all TBI cases are categorized as mild (“mTBI”). Still, these approximations are considered underestimates “because they do not account for incidents of TBI in which the person does not seek medical care.”

Concussions are frequent in contact sports, with soldiers making up another significant proportion of people who frequently sustain these injuries multiple times over their careers. Latest statistics show that over 430,000 U.S. service members were diagnosed with a TBI from 2000 to 2020 (https://ibn.fm/OpnXq), with 75-83% of these cases having been categorized as mild (“mTBI”) (https://ibn.fm/PhTRQ). In addition, one analysis notes that one in six soldiers returning from deployment in Iraq met the criteria for concussion.

For a long time, however, concussions did not receive the necessary urgency and attention to understand the underlying mechanisms of mild brain trauma and device potential therapeutic interventions. In fact, a New York Times article notes, many soldiers used to shrug off ailments that began following blasts – headaches, dizzy spells, numbness in their arms, dehydration, fatigue, and persistent ringing in their ears – only to later develop even more severe symptoms a few years after the explosions (https://ibn.fm/Lm1dd). But Odyssey is now spearheading efforts to understand the condition and develop treatments for concussion, which until now, does not have an FDA-approved drug.

Odyssey is developing the PRV-002, a novel compound for the treatment of concussion. The drug is currently undergoing evaluations as part of a Phase I clinical trial. Upon completing the Phase 1 trial, presenting its findings to the FDA for review, and after receiving positive feedback, Odyssey intends to initiate a Phase II clinical trial in the U.S., starting with the military. This is where the Military Advisory Board will play a crucial role.

The board comprises Major General USA (r) and Former Chief of Staff USSOCOM James Linder, Commanding General U.S. Army Special Operations Command (r) Francis Beaudette, Lieutenant Colonel (r) Paul Toolan, and Vice Admiral (r) Timothy Szymanski, leaders who understand firsthand the consequences of TBI on the battlefield as well as its impacts on retired and separated service members. They equally recognize the role leaders at all levels have to play to protect the comprehensive brain health of their soldiers and the underlying need to passionately and aggressively pursue treatment.

“Too many service members and veterans are suffering from post-concussive events, while their families are suffering as they watch and provide care. There remains an urgent need for a concussion treatment at the point of injury that immediately treats the initial injury, speeds recovery, and potentially diminishes its long-term effects. We are obligated to pursue treatments that improve a service member’s, and their families’, well-being through their service commitment and beyond,” commented Vice Admiral (r) Timothy Szymanski (https://ibn.fm/hHCeO).

For more information, visit the company’s website at https://odysseygi.com/.

NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

Home Bistro Inc. (HBIS) Sees Triple-Digit Revenue Growth, Success in Meal-Delivery Platform

  • The company’s latest financial report shows a record revenue increase of 127%
  • Company anticipates continued record top-line growth
  • HBIS is making significant strides in efforts to increase its gross profit margin, decrease operating expenses to close the gap to profitability; positive earnings are expected in 2023

The market for online meal delivery is booming, as evidenced by triple-digit revenue growth reported by Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers exclusive celebrity chef-inspired, gourmet and lifestyle ready-made meals. The company’s latest financial report shows a record revenue increase of 127% over the same period the year before (https://ibn.fm/FqHzP).

“With more chefs coming online earlier this fiscal year, we are continuing to see record top line growth,” stated Home Bistro CEO Zalmi Duchman. “As I have previously stated, our goal is to continue growing our revenue at a significant rate while eyeing profitability by 2023. To this end, over the past few months we have been taking significant steps to increase our profit margin and considerably decrease our general and administrative expenses.”

HBIS released Q2 2022 financial information for the quarter ended April 30, 2022, including revenue highlights and an update on the company’s focus on strategic financial management. The report shows that product sales for the quarter increased 127% to $743,263, compared to revenues of $328,024 for the same period in 2021. The company noted that the increase was linked to its integration of the Model Meals brand along with consistent product sales from celebrity chefs Cat Cora and Daina Falk and the launch of Claudia Sandoval and Richard Blais.

The company has also made significant efforts to control operating expenses and net loss. “In order to accomplish this, we have undertaken multiple initiatives,” said Duchman. “First, we have significantly reduced minimum guaranteed royalty payments to new celebrity chefs, and older, more costly guaranteed deals will begin to expire in 2023.” The company anticipates adding three more celebrity chefs and two add-on partnership offerings in the coming weeks.

In addition, Duchman noted that the company is taking steps to reduce its product costs and retail prices, which will have a positive net effect on gross margin. Finally, “our recently announced collaboration with public relations firm Alab Group should benefit us by offsetting more expensive online advertising costs with a less costly but equally, if not more effective, influencer-based strategy,” he said.

“We have grown as a publicly traded company over the past several years, and as we continue to work toward a potential Nasdaq uplisting, we will be significantly less reliant on costly external consultants and other professional service providers,” he continued. “Lastly, having just launched our subscription-based Model Meals program, we believe we can experience a much smoother path to a recurring revenue model, which we also plan to introduce for our Home Bistro and celebrity-chef brands in the near future.”

Home Bistro is a leading online platform that provides for the creation, production and distribution of direct-to-consumer, heat-to-eat, celebrity-chef-inspired gourmet meals. Current HBIS offerings ceom from Iron Chef Cat Cora, Ayesha Curry, Hungry Fan Chef Daina Falk, Master Chef Claudia Sandoval, Top-Chef All-Star Richard Blais, and celebrity pastry and dessert chef Melanie Moss; celebrity chefs Roblé Ali and Priyanka Naik are set to add their selections soon.

Home Bistro’s Model Meals lifestyle brand is a Whole30 and Paleo approved, ready-to-eat, meal-prep service, offering a weekly rotating menu that is prepared by professional chefs, using only the highest-quality ingredients available, sourced responsibly and locally, and delivered in sustainable, ecofriendly packaging.

For more information, visit the company’s website at www.HomeBistro.com.

NOTE TO INVESTORS: The latest news and updates relating to HBIS are available in the company’s newsroom at https://ibn.fm/HBIS

Sycamore Entertainment Group Inc. (SEGI) Is ‘One to Watch’

  • Sycamore Entertainment Group Inc., through subsidiary SEGI.TV, offers a streaming experience built on the pillars of equality, sustainability and community
  • SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others
  • Sycamore has entered sponsorship agreements for multiple motorsports events in an effort to connect with global influencers and build brand awareness
  • Ad-supported video on demand revenues are predicted to more than double between 2018 and 2024 to reach $56 billion across 138 countries

Sycamore Entertainment Group (OTC: SEGI) is a diversified entertainment company specializing in the acquisition, marketing and worldwide distribution of quality finished feature-length motion pictures.

Through wholly owned subsidiary SEGI.TV, the company offers a streaming experience built on the pillars of equality, sustainability and community. SEGI.TV taps into the changing cultural environment, offering movies and television programming for a diverse audience – all without a subscription fee.


Launched in late 2020, SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others. The OTT streaming network operates via an ad-supported video on demand (“AVOD”) model, allowing Sycamore to control revenue growth by negotiating rates with advertisers as its userbase continues to expand.

The company expects this AVOD model to help SEGI.TV more efficiently grow its market share while avoiding direct competition with subscription service players such as Netflix and Hulu. Other industry players who have leveraged and grown through the ad-based revenue model include Tubi (33 million monthly users, acquired by Fox), YouTube (2 billion monthly users, acquired by Google) and Pluto TV (28 million monthly users, acquired by NBC/Viacom).

SEGI.TV lives up to its brand promise of inclusion, equality and community by:

Attracting Original/Hard-to-Find Content

SEGI.TV features uplifting content aimed at helping its users tap into the changing cultural environment, including movies, TV and sporting events, and the company continues to seek-out new and engaging programming.

On March 19, 2022, SEGI.TV streamed the long-awaited grudge match between Hafthor Bjornsson and Eddie Hall, former World’s Strongest Men. Deemed ‘The Heaviest Boxing Match in History’, the bout was available to watch in just two clicks for free, without any time-specific trials, paywalled content or sneaky subscriptions.

In speaking about the match, Sycamore CEO Edward Sylvan stated, “With live streaming sports revenues expected to quadruple by 2028, we at SEGI.TV are uniquely positioned to capitalize on this new ad supported model.”

Making Inroads with New Users

As consumers continue to shift away from traditional cable and satellite toward OTT streaming, existing options are divided into two primary categories – ad-supported and premium. While industry giants like Netflix, Disney and Apple target customers with non-ad-supported options, SEGI.TV’s AVOD model positions it as a solid alternative for individuals who are reluctant to commit to a subscription-based platform.

Increasing Viewership through Branding and Awareness

Sycamore has entered sponsorship agreements for multiple motorsports events in an effort to connect with global influencers and build brand awareness.

  • SEGI.TV sponsored the No. 10 Dallara-Honda of Alex Palou when he took the checkered flag, winning the Honda Indy Grand Prix of Alabama at Barber Motorsports Park.
  • SEGI.TV sponsored the No. 50 car of Floyd Mayweather’s TMT Racing for NASCAR’s Coca-Cola 600 at Charlotte Motor Speedway.
  • SEGI.TV sponsored the No. 99 SEGI.TV GMC HUMMER EV.R in the Extreme E all-electric global racing series, which focuses on bringing awareness to environmental and equality issues worldwide.
  • SEGI.TV has the North American broadcast right to the all-electric eSkootr Championship

Market Opportunity

The gradual move away from traditional cable and satellite TV subscriptions in the U.S. and around the world has created an opportunity for streaming companies to capitalize. According to data from Statista, the number of pay TV households in the U.S. declined from a peak of 100.5 million in 2014 to roughly 73 million in 2021. Likewise, pay TV revenue in the U.S. decreased from $104 billion in 2015 to $74 billion in 2021.

The loss for cable and satellite providers has corresponded with a boom for video-on-demand services. Subscription video-on-demand (“SVOD”) revenue in the U.S. reached $25 billion in 2021. According to Digital TV Research, AVOD revenues are predicted to more than double between 2018 and 2024 to reach $56 billion across 138 countries. Even SVOD mainstay Netflix is exploring AVOD as a way to combat declining subscription numbers.

As Sycamore continues to expand SEGI.TV with new, unique and eventually premium content, it is uniquely positioned to benefit from this industry trend. Through its FAST (Free Ad-Supported TV) channels, SEGI.TV positions Sycamore as one of only a handful of publicly traded, pure play companies operating in the space.

In an October 2021 report, Variety called FAST “the latest avenue for established media and entertainment companies,” and recent moves by entertainment mainstays support this notion. In April 2022, Amazon rebranded its FAST-focused AVOD service to Amazon Freevee and highlighted the rapid growth of the platform, which has tripled its monthly active users.

“Advertising video-on-demand (‘AVOD’) and free ad-supported TV (‘FAST’) channels are the biggest winners of the Streaming Wars, we believe, because ‘free’ always has the largest TAM (total addressable market),” Laura Martin, an analyst with equity research firm Needham, said in a recent note to clients.

Management Team

Edward Sylvan is the CEO and Co-Founder of Sycamore. He has more than 30 years’ experience in the financial service and banking industry. His banking expertise helped cultivate more than 20 years of entertainment industry relationships.

Terry Sylvan is the company’s CMO and Co-Founder. He brings to Sycamore more than 25 years of marketing and advertising experience, from global brand assignments to film marketing.

For more information, visit the company’s website at www.SycamoreEntertainment.com.

NOTE TO INVESTORS: The latest news and updates relating to SEGI are available in the company’s newsroom at https://ibn.fm/SEGI

NFT Expoverse Draws Massive Interest and Coverage From All Spheres

Enthusiasts, entrepreneurs, and the curious about industries involved with crypto, arts, music, tech, esports, and more are all invited to attend NFT Expoverse. This event will be held in Los Angeles, California from the July 29-31, 2022. While 2021 proved a turning point for the blockchain space, interest in blockchain technologies and NFTs seem to be increasing even more rapidly in 2022, making it a perfect year for an event like NFT Expoverse.

The city of Los Angeles is perfect for this conference as it’s a historical melting point of culture, technology, and recreation. The event will gather some of the industry’s most sought-out speakers, all of whom will share their insights obtained from their own personal experiences in the field. Attendees will come out as experts themselves by the end of the event!

All of NFT Expoverse’s participants can learn, connect with peers, seek guidance, build long-term business ties with their mentors, and conduct business with top-rated brands. This event is the complete package for enthusiasts and beginners, allowing them to dive into all things web3, cryptocurrency, NFT markets, and metaverse experiences.

Blockchain technologies are opening up a world of possibilities, among them the ability to mint what is known as NFTs (Non-fungible tokens). These blockchain based tokens represent unique digital assets like art, music, videos, and gaming items. NFTs are encrypted with the creator’s signature and use blockchain software to verify the ownership and originality of the assets. That being said, tons of creators from around the globe are now preparing for an exciting opportunity to elevate their careers at NFT Expoverse.

Brands can leverage NFT Expoverse’s opportunities by bringing their products and services to the forefront as exhibitors throughout the event. This will allow them to connect with potential investors and engage with the audience in real life.

“NFT Expoverse gives everyone the chance to connect in person, ask their questions in real-time, and take part in experiences they won’t be able to have over a Zoom. This event is extremely unique as it caters to attendees like my parents (the curious) all the way to those already established in this industry (the creators) and everyone in between.” Nicole Beiner, Marketing Director of NFT Expoverse.

The team behind NFT Expoverse wants to ensure a one-of-a-kind experience by having unique immersive experiences, an NFT art gallery, VIP experiences, and much more. Additionally, this event is being held by a company called ZJ Events, which has an extensive background in creating unique trade show experiences in alternative industries.

Those who purchase their tickets early on will get access to special offers. Plus, they have partnered with several hotels nearby the venue to make your visit even smoother. Attendees will have access to refreshments and a networking break, in addition to speaking sessions and hundreds of exhibits. The icing on the cake is that after the immersive sessions are over, participants can enjoy NFT Expoverse’s official after party!

To get tickets, please visit https://nftexpoverse.com.

Zacks Report Highlights Flora Growth Corp. (NASDAQ: FLGC) Aspiring to Benefit from First Mover Advantage in Multiple Cannabis Market Categories

  • Flora’s 2021 acquisitions allowed it to expand its operations beyond North America and into Europe
  • Acquisitions have also contributed to 450% YOY revenue growth for Q1 2022
  • Its management is confident that the foundation laid down so far will yield growth for 2022 and subsequent financial years
  • Flora has also reiterated 2022 revenue guidance of $35 million to $45 million

2021 was an excellent year for Flora Growth (NASDAQ: FLGC). According to a recent research report from Zacks (https://ibn.fm/xnXve), the company possesses a number of important qualities pointing to continued significant growth following a strong 2021. Flora Growth management even regarded the past year as “transformational,” particularly following the closing of supplier, vendor, and distribution agreements that would see the company expand its operations, market reach, and product line.

With the progress made by the company so far, it is looking to benefit from a first-mover advantage in multiple market categories in terms of increased value for its shareholders, a higher market share, and increased revenue going forward.

The report went on to talk about 2021’s acquisition of Vessel Brand, Inc., a move that allowed the company to establish a foothold in the United States cannabis accessories business while improving its e-commerce capabilities. The year would also see the construction of an all-outdoor cultivation and on-site extraction facility in Colombia, one of the largest traditional flower exporters in the world and now able to export cannabis flowers.

Such moves position Flora to take advantage of the potential of the marijuana industry, particularly the medical marijuana sector. According to a report from Grand View Research, the global medical marijuana market size was valued at USD 11.0 billion in 2021 and is projected to expand at a compound annual growth rate (“CAGR”) of 21.6% from 2022 to 2030 (https://ibn.fm/orzCj).

Through its acquisitions, Flora has expanded its operations beyond North America and into Europe. The company’s investment in Hoshi International, for instance, opened it to the European Union (“EU”), allowing it to expand its global footprint that would further spread to Hong Kong, Latin America, and Israel.

The report also pointed out Flora’s Life Sciences pillar, one of its three key pillars of growth, focused on providing scientific-based research associated with cannabis. The other two pillars include Commercial and Wholesale and House of Brands. The company believes that, while offering the products in its portfolio is critical, educating consumers and potential customers is of the essence if the conversation around cannabis is to be advanced. Therefore, Flora remains committed to creating educational platforms and conducting research studies and clinical trials to develop plant-based, medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements.

Through its acquisitions and growing distribution network, Flora was able to post a 450% year-over-year revenue growth for the first quarter of the 2022 financial year. As a result, its management is confident that, for the entire fiscal year, the company will post between $35 million and $45 million in revenue.

This will be significantly influenced by the JustCBD acquisition, the awarding of an export quota for 43.6 tons of high-THC cannabis in Colombia, and the successful completion of the requisite steps to allow for the commercial planting and export of psychoactive cannabis.

Flora looks to reach cash flow breakeven as revenue continues to ramp, having closed the 2021 fiscal year with about $37.6 million in cash and a $21.4 million loss. 2021 was its first full year of revenue. Still, the company anticipates accelerating revenue growth in 2022 as it activates its Wholesale and Life Sciences growth units while simultaneously fueling expansion in the global House of Brands.

Flora is aggressively pushing its brand and advancing the conversation around cannabis. In addition, with its able management, Flora is recognizing and capitalizing on opportunities that others are yet to identify, placing it in a unique position that not only gives it a first-mover advantage, but also presents a unique opportunity for growth.

The full Zacks Small-Cap Research Report is available at https://ibn.fm/xnXve.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leveraging Lightning Network to Spread Bitcoin Awareness Through Worldwide Channel Access

  • The Lightning Network capacity is US $82,800,210
  • LQwD’s longest running node is US-West, with a capacity of 5.74404405 BTC/ 574,404,405 sat/ US $117,517.28, a channel count of 107, and a node count of 106
  • LQwD has a total of 17 active nodes worldwide on the Lightning Network
  • The global cryptocurrency market was valued at US $1.49 billion and is expected to reach US $4.94 billion by 2030

Five years ago, on May 10, 2017, Christian Decker of Blockstream made the first non-test transaction on the Lightning Network. The transaction, conducted in Litecoin, was settled within one second. Today, the Lightning Network has grown on a massive scale, with over 17,000 nodes and almost 85,000 channels. The Network’s capacity, as of June 23, 2022, was US $82,800,210. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, has invested its own reserves in enhancing the experience of the Lightning Network.

In November 2021, LQwD launched its first node and proprietary platform as a service offering (“PaaS”), https://lqwd.tech/, to the public. As LQwD’s longest operational node, US-West has a capacity of 5.74404405 BTC/ 574,404,405 sat/ US $117,517.28, a channel count of 107, and a node count of 106. A satoshi (“sat”) is the smallest measurable unit of BTC, equal to 0.00000001 BTC, and is named after Bitcoin creator Satoshi Nakamoto.

Since the initial launch of the US-West node, the company has released 16 other nodes worldwide. In addition to US-West, LQwD’s presence on the Lightning Network includes Hong Kong, Ireland, India, Germany, Brazil, Singapore, Sweden, South Korea, South Africa, Bahrain, Indonesia, Italy, France, Canada, England, and Japan. Collectively, LQwD’s nodes range in size with channel counts spanning 2 (newer nodes) to 107 (US-West). To learn more about the Lightning Network and LQwD’s node operations, visit www.1ml.com.

The blockchain infrastructure cannot facilitate fast transaction speeds on its own. Currently, the infrastructure can only accommodate seven transactions per second (“TPS”). Other cryptocurrencies offer a TPS ranging from 20 to 4,000, with major network Visa handling up to 24,000 TPS. As a layer 2 protocol, the Lightning Network can speed up transaction times, offering over one million TPS. LQwD is leveraging this technological advantage to drive bitcoin adoption and facilitate transactions worldwide.

In its mission to accelerate bitcoin adoption, LQwD, through subsidiary Coincurve.com, joined Visa’s (NYSE: V) Fintech Fast Track Program. According to Shone Anstey, LQwD CEO, “Our direct relationship with Visa now gives LQwD the advantage of accessing their growing partner network, as well as experts in the payments space. It’s a big benefit” (https://ibn.fm/036g2).

Driving bitcoin adoption is critical on a fast-growing global cryptocurrency market, despite recent volatility in the space. In 2020, the global cryptocurrency market was valued at US $1.49 billion. By 2030, this market is expected to reach US $4.94 billion, growing at a CAGR of 12.8%. Driving factors for growth include the increased need for operational efficiency, transparency in financial payment systems, the demand for remittances in developing countries, increased data security, and improved market cap (https://nnw.fm/d5wBo). (https://ibn.fm/FPE75).

El Salvador was the first country to convert its legal tender to cryptocurrency. Other countries have expressed an interest in doing so, but few have made the official move. Unlike fiat currency, cryptocurrency is not asset-backed (or government-backed), making it more volatile than the standard dollar bill. Fiat currency has its volatility, too. As the government economic factors shifts, so does the value of the dollar. Once worth its weight in gold, the dollar faced devaluation when President Nixon ended the conversion for gold in the 1970s, proving that even the most stable payment systems can sometimes become volatile (https://ibn.fm/F60sB).

For more information, visit the company’s website at www.LQwDFinTech.com.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

Mullen Automotive Inc. (NASDAQ: MULN) Retrofits Existing Facility to Move EV Battery Pack Production In-House

  • Global EV market projected to see 24.5% CAGR between 2022 and 2028
  • MULN announces plans to modify high-voltage plant to produce packs used for company’s EVs
  • Company anticipates using its own revolutionary solid-state battery technology in its second-generation Mullen FIVE EV Crossovers
  • Strategic move reduces company’s reliance on third-party suppliers, reduces impact of supply and critical component shortages

Amid a growing global demand for electric vehicles (“EV”), smart companies operating in the space are looking for ways to differentiate themselves from the competition. That’s exactly what Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle manufacturer, has done with its recently announced plans to retrofit a high-voltage facility for production of EV battery packs to support its growing line of electric vehicles (https://ibn.fm/PqP6H). The company expects to also eventually begin the development of solid-state polymer battery packs, which will be a significant advancement over current lithium-ion battery packs (https://ibn.fm/ZdV37).

According to a recent Facts & Figures report, the “global electric vehicle (‘EV’) market size is estimated to cross USD $980 billion by 2028, at a CAGR of 24.5% between 2022 and 2028” (https://ibn.fm/VEK4I). The report, which looked at a variety of different factors and their projected impact on EV market growth, noted that “a variety of batteries are used in these vehicles.

“The electric vehicle was developed primarily to replace polluting traditional ways of transportation,” the report continued. “As a result of various technological developments, it has gained in popularity. [An EV] outperforms traditional automobiles in terms of fuel efficiency, carbon emissions, and maintenance, as well as ease of charging at home, a smoother ride, and less engine noise. Pure, hybrid, and plug-in hybrid batteries are the three primary types of electric car batteries.”

Mullen, an emerging electric vehicle manufacturer, recently announced that it plans to begin EV battery-pack production in its California-based high-voltage-battery research-and-development facility. In order to do so, the company is modifying an existing facility to house production of EV battery packs, which will be used in the company’s EVs, including the ONE EV Cargo Van, FIVE EV Crossover and DragonFLY EV Sportscar.

“Building our own battery packs makes sense as it reduces our reliance on third-party suppliers and lessens our risk of being subjected to the waves of supply and critical component shortages,” said Mullen CEO and chair David Michery. “The entire industry is struggling with supply chain issues, and the more control we have in-house, the better off our vehicle programs will be. Our Monrovia facility is already established for high-voltage applications, so retrofitting it for our battery-pack development makes good sense for our company and shareholders.” In addition to reducing third-party dependency, the move to bring battery-pack production in-house will lower costs and increase overall quality control, Michery noted.

For almost a decade, the facility was used for battery-pack research, development and production for CODA Automotive; Mullen purchased the assets from CODA in 2014 and took over plant production in 2017. The move to focus on battery production for Mullen-specific EVs makes sense as the company continues to expand its vehicle portfolio.

In addition, the company is testing its own solid-state polymer battery technology, which has the potential to deliver more than 600-plus miles of range and features an 18-minute DC fast charge that can yield more than 300 miles of range. The company anticipates using this new battery technology in its second-generation Mullen FIVE EV Crossovers (https://ibn.fm/62cfG).

According to the company, since its first quarter as a public company in 2021, Mullen has debuted two versions of the Mullen FIVE show cars, as well as continuing to focus on its development portfolio. The company also purchased a facility in Tunica, Mississippi, where it plans to start with the manufacturing of the Mullen ONE EV Cargo van program, which is slated for availability in Q2 2022. The company is capturing attention with its lineup of vehicles. The Mullen FIVE was named Top Zero Emission SUV as part of the ZEVA Awards at the Los Angeles International Auto Show in November 2021, and the company has filed more than 120 patents in 24 countries related to the vehicle.

Mullen is a Southern California–based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

Aditxt Inc. (NASDAQ: ADTX) Authorizes New Channel Partner to Offer AditxtScore(TM) Amid Rising COVID-19 Cases and Possible Fall/Winter Waves

  • Aditxt, Inc. is a is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The Company’s product AditxtScore(TM) is a proprietary immune mapping technology designed to provide a personalized profile of the immune system; AditxtScore(TM) for COVID-19 is the Aditxt’s first commercial product
  • Aditxt recently announced it had authorized a new channel partner – Premier Medical Laboratory Services (“PMLS”), a leading advanced medical diagnostics lab –to offer AditxtScore(TM)
  • This announcement comes amid reports warning of a fall and winter COVID-19 wave occasioned by waning immunity or a possible “nasty new variant”
  • Already, the U.S. is undergoing a sixth wave even before the start of the summer

During the one week to May 18, the U.S. averaged roughly 100,000 COVID-19 cases each day, representing an increase of more than 3x from the lowest figure reported in March, yet the numbers did not include at-home test results, according to a Washington Post article. The piece quotes experts’ assumptions that the infections in their communities are five to ten times the official counts (https://ibn.fm/QgkXo).

Despite the disparity in the reported figures, the sheer number of infections is still a cause for concern, with White House health officials urging Americans to stay up-to-date with vaccines and booster shots, get tested, and wear masks. And as the country ushers in the summer season, experts are quick to sound alarm bells, warning that this summer’s surge in COVID-19 cases could be worse than last year’s because the May 2022 cases were considerably higher than they were a year earlier.

“Federal officials have also warned of a possible fall and winter wave that could result in 100 million coronavirus infections driven by omicron subvariants that have shown a remarkable ability to escape immunity,” the article reads. Christopher Murray, Director of the Institute for Health Metrics and Evaluation, told the Washington Post that the anticipated spike in COVID-19 cases this fall and winter could be the result of a substantial dip in immunity or “some nasty new variant.” Already, the U.S. is undergoing a sixth wave even before the start of the summer (https://ibn.fm/wkCPJ).

The immunity’s role in keeping SARS-CoV-2 – the virus that causes the COVID-19 disease – at bay has been recognized and appreciated by many experts and companies, one of which is Aditxt (NASDAQ: ADTX). Aditxt provides the AditxtScore(TM), a proprietary immune mapping technology designed to provide a personalized profile of the immune system.

Licensed from Stanford University, AditxtScore(TM) for COVID-19 is Aditxt’s first commercial product. It enables patients to know the level of protection that an immune response to the SARS-CoV-2 virus or vaccination confers them. This product can be used routinely to establish changes in immune response over time (immunity trends) and provide information crucial to understanding the virus, especially amid reports of a possible fall and winter wave. The results may also influence the vaccine-hesitant populace to take the vaccine, particularly when it is determined that they are not protected by antibodies.

Generally, the AditxtScore(TM) results offer information on whether an individual has antibodies that will protect them against the virus; if the antibodies are a result of vaccination or an immune response to a virus; whether the immune response is likely to protect against future infection; and the possible ways to minimize the risk of a future infection.

The benefits of AditxtScore(TM) will now be felt by an even larger population following a recent announcement that Premier Medical Laboratory Services (“PMLS”), a leading advanced medical diagnostics lab, has added this product to its list of testing services. Under the terms of this arrangement, PMLS is an authorized channel partner that will offer AditxtScore(TM) (https://ibn.fm/MvMdX).

“As new variants emerge, we want to equip physicians with the most advanced tests that allow a comprehensive view of their patient’s health status,” commented Kevin Murdock, CEO of PMLS. “With AditxtScore(TM), individuals can make more informed decisions about whether vaccination, boosters, or other risk mitigation strategies are the right course of action for them.”

PMLS joins a list of channel partners that includes the Great Lakes Medical Laboratory, Inc., The Health Watchers, Physicians Stat Lab, Sphere Dx Laboratory, and HealthBar. These partners collect and ship samples to the AditxtScore(TM) Center, Aditxt’s high complexity CLIA-certified, CAP-accredited lab, where the specimens are prepped and profiled by a team of lab scientists trained at prestigious institutions. According to the company, the results are usually readied within 48 hours of specimens’ receipt (https://ibn.fm/F3BYU).

Correlate Infrastructure Partners Inc. (CIPI) Collaborates with Abundant IoT for the Correlate Portfolio Health Program Launch

  • This program seeks to develop revenue generation for commercial real estate owners, affording them new revenue and rent opportunities using their existing energy assets
  • The program will involve portfolio health assessment, design, development, and implementation of turnkey clean electrification solutions for clients
  • Correlate and Abundant IoT seek to reduce friction between property owners and service providers, allowing them to meet their ESG goals

On June 21, 2022, Correlate Infrastructure Partners (OTCQB: CIPI) announced the official launch of its Correlate Portfolio Health Program, unveiled at the Channel Partner Conference and Expo that ran from April 11-14 in Las Vegas. The program, which will be executed in partnership with Abundant IoT, seeks to develop a revenue generation program for commercial real estate owners, thereby affording them new revenue and rent opportunities from their current energy assets (https://ibn.fm/URl9q).

“The path to full decarbonization will take ambition and intentional execution,” noted Todd Michaels, Correlate’s Chief Executive Officer (“CEO”).

“By teaming up with industry innovators and experts, we can guide commercial real estate owners in creating new revenue and rent opportunities from their existing energy assets,” he added.

Abundant IoT provides worldwide technology aggregation services focused on the Internet of Things (“IoT”) and energy services. Since January 2022, this enterprise has identified and referred to Correlate over 50 commercial facilities with projected development revenue of approximately $10 million. Correlate is still in the process of pursuing and negotiating with the property owners.

Together, Abundant IoT and Correlate seek to reduce friction between property owners and service providers, thereby improving their net operating income while allowing them to meet environmental, social, and governance (“ESG”) goals. In addition, these two enterprises recognize the opportunities in IoT and decarbonization. They are working towards tapping into this opportunity to bring their services closer to consumers.

“According to Transforma Insights research, the global IoT market is set to grow to 24.1 billion devices in 2030, generating $1.5 trillion in annual revenue,” noted Vince Bradley, the founder of Abundant IoT.

“The time is now for IoT and decarbonization solutions in the channel,” he added.

The Portfolio Health program will start with a portfolio health assessment. Once completed, Correlate and Abundant IoT will design, develop, and manage the implementation of turnkey clean electrification solutions focused on locally sited solar, energy storage, electric vehicle (“EV”) infrastructure, and intelligent efficiency measures.

Ultimately, the objective is to enable commercial real estate owners to benefit from the global transition to clean energy without getting into the energy business. Through this program, entrepreneurs and real estate owners can start capturing new revenue and offering enhanced tenant benefits while simultaneously increasing the overall value of their commercial real estate portfolios.

The launch of this program comes in the wake of the rise in remote work, increased corporate decarbonization commitments, and growing investor demands for ESG standards. This has forced the commercial real estate sector to adjust, making the Correlate Portfolio Health Program ideal for generating long-term value for tenants, investors, communities, and employees.

“Cloud proliferation coupled with the pandemic has created the ideal market opportunity for a new channel model built around IoT. Combining energy, mobility, and connectivity with the devices is a very powerful go-to-market package for customers,” noted Mr. Bradley.

For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

From Our Blog

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Plans to Reach 24 Countries by Q4 2022

July 1, 2022

LQwD currently has Lightning Network nodes in 17 countries with a goal of 24 by the end of Q4 2022 The current LQwD nodes have already processed over 10k transactions, and the number is climbing The global cryptocurrency market was valued at US $1.49 billion in 2020. The market is projected to reach US $4.94 […]

Rotate your device 90° to view site.